Not every breakthrough changes the world. This discussion explores what it really takes to scale - blending cutting-edge science, digital technologies, and resilient supply chains to move innovation from lab bench to bedside.

Speakers:
• Mr. Eamonn Warren, VP, API and Dry Products Manufacturing, Eli Lilly and Company, USA
• Dr. Despina Solomonidou, EVP, Global Head Technical Research & Development, Novartis, Switzerland
• Ms. Rashmi Kumar, SVP & Chief Information Officer, Medtronic, USA
• Dr. Peter Owotoki, Cofounder & CEO, EmpathicAI.life Ltd, Germany
• Prof. Kil To Chong, Founder & CEO, JuYoungBio Corporation, South Korea
• Dr. Kenneth Barr, SVP, Head of Strategic Collaborations, Head of SynVent, Syngene

Moderator: Mr. Daniel Mathews, EY Global and EMEIA Life Sciences Sector Lead, UK

Pharma and biotech CEOs dissect growth headwinds - pricing pressure, regulatory shifts, talent shortages - and reveal the growth engines they’re betting on for the next five years.

Speakers:
• Dr. Peter Piot, Professor of Global Health & EU Chief Scientific Advisor Epidemics
• Mr. Vikrant Shrotriya, MD, Novo Nordisk India
• Mr. Giuliano Perfetti, CEO & MD, Jubilant Biosys Limited
• Mr. Srinath Venkatesh, MD, India and South Asia, Thermo Fisher Scientific
• Mr. Amit Mookim, CEO, Immuneel Therapeutics Private Limited
• Mr. Hari Buggana, Founder and Chairman, InvAscent

Moderator: Mr. Suresh Subramanian, Partner and National Life Sciences Leader, EY

The panel will discuss how next-generation biologics and advanced modalities, including cell & gene therapies, mRNA, and radiopharmaceuticals, are progressing from discovery to clinical proof and scalable CMC, with generative AI and advanced computational tools increasingly supporting decisions across target design, process development, analytics, and manufacturing readiness.

Keynote Address: Dr. Stefan Miltenyi, Founder & President, Miltenyi Biotec, Germany

Speakers:
• Dr. Raches Ella, Chief Development Officer, Bharat Biotech
• Dr. Darrin Morrissey, CEO, NIBRT, Ireland
• Dr. Sangita Reddy, Joint MD, Apollo Hospitals Group
• Mr. V. Simpson Emmanuel, President at ImmunoACT
• Dr. José Castillo, CEO, Quantoom Biosciences, Belgium
• Dr. Madhuri Vusirikala (MD), VP, Actinium Pharmaceuticals, USA

Moderator: Mr. Gil Bashe, Chair Global Health and Purpose, FINN Partners, USA

This session intends to showcase the impact and outcomes enabled by Healthcare GCCs on what matters: the end-patient. GCC capabilities have evolved greatly over the years, and KPMG will enable conversations with senior Healthcare leaders to understand the far-reaching impact of Healthcare GCCs. During this session, KPMG will also release a whitepaper curating key patient-impact narratives from select Healthcare GCC organisations.

Speakers:
• Ms. Siva Kumar Padmanabhan, MD & Head of Global Innovation & Technology Centre, AstraZeneca
• Ms. Chandani Palshetkar, Global Head of Strategy, Hub & Services, Opella Healthcare
• Dr. Anand Jain, Vice President, Product & Portfolio Strategy, Novo Nordisk
• Mr. Manish Arora, AVP and GM, Eli Lilly Services India Pvt. Ltd.
• Mr. Mahesh Natarajan, Senior Director, Thermo Fisher Scientific
• Mr. Srinivas Peddi, Senior Director & Centre Head, Becton Dickinson Technology Campus

Moderator: Ms. Shalini Pillay, Partner at KPMG and India leader, GCC

India’s innovation landscape is expanding rapidly, yet challenges in funding, talent, and commercialization continue to shape the pace of progress. This session explores where India stands today, and what it will take to accelerate impact at scale.

Speakers:
• Ms. Preeti Sudan IAS (Retd.), Former Chairperson, UPSC and Former Union Health Secretary, Government of India
• Dr. Jitendra Kumar, MD, BIRAC, DBT, Government of India
• Dr. Murali Ramachandra, CEO, Aurigene Oncology
• Mr. Sridhar Gopal, Head of International Business Development, AbbVie, USA
• Mr. Nataraj Kalyanaraman, VP, Head of Drug Development, BMS
• Mr. Sanjeev Sachdeva, Global Head - Advisory and Business Process Services, Life Sciences, TCS
• Mr. Raja Jammalamadaka, Head, Roche Digital Centre
• Mr. Greg Killian, SVP & GM, Global Life Sciences & Healthcare, EPAM Systems, USA

Moderator: Mr. Vikas Dandekar, Editor (Pharma & Healthcare), The Economic Times